Medifast (MED) Tops Q3 EPS by 48c

Medifast (NYSE: MED) reported Q3 EPS of $3.56, $0.48 better than the analyst estimate of $3.08. Revenue for the quarter came in at $413.4 million versus the consensus estimate of $403.76 million.

For earnings history and earnings-related data on Medifast (MED) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• Baidu (BIDU) Misses Q2 EPS by 262c, misses on revenue